Fabrication of levofloxacin-loaded porcine acellular dermal matrix hydrogel and functional assessment in urinary tract infection
Authors:
Open Access
- 7 February 2024
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 22 (1) , 1-18
Abstract
Bacterial cystitis, a commonly occurring urinary tract infection (UTI), is renowned for its extensive prevalence and tendency to recur. Despite the extensive utilization of levofloxacin as a conventional therapeutic approach for bacterial cystitis, its effectiveness is impeded by adverse toxic effects, drug resistance concerns, and its influence on the gut microbiota. This study introduces Lev@PADM, a hydrogel with antibacterial properties that demonstrates efficacy in the treatment of bacterial cystitis. Lev@PADM is produced by combining levofloxacin with decellularized porcine acellular dermal matrix hydrogel and exhibits remarkable biocompatibility. Lev@PADM demonstrates excellent stability as a hydrogel at body temperature, enabling direct administration to the site of infection through intravesical injection. This localized delivery route circumvents the systemic circulation of levofloxacin, resulting in a swift and substantial elevation of the antimicrobial agent’s concentration specifically at the site of infection. The in vivo experimental findings provide evidence that Lev@PADM effectively prolongs the duration of levofloxacin’s action, impedes the retention and invasion of E.coli in the urinary tract, diminishes the infiltration of innate immune cells into infected tissues, and simultaneously preserves the composition of the intestinal microbiota. These results indicate that, in comparison to the exclusive administration of levofloxacin, Lev@PADM offers notable benefits in terms of preserving the integrity of the bladder epithelial barrier and suppressing the recurrence of urinary tract infections. Graphical AbstractKeywords
Funding Information
- National Natural Science Foundation of China (81973983, 82270015, 82100017, 82302577, 82304209, 82370016)
- Anhui Provincial Natural Science Foundation (2208085QH236, 2308085QH284, 2308085MH243, 2208085MH264)
- Anhui Province Scientific Research Planning Project (2023AH010083, 2023AH053282)
- Joint construction project of clinical medicine university and hospital (2021lcxk006)
- China Primary Health Care Foundation (MTP2022A015)
This publication has 74 references indexed in Scilit:
- Enhanced immunostimulatory effects of DNA-encapsulated peptide hydrogelsBiomaterials, 2015
- Urinary tract infections: epidemiology, mechanisms of infection and treatment optionsNature Reviews Microbiology, 2015
- Uropathogenic Escherichia coli Superinfection Enhances the Severity of Mouse Bladder InfectionPLOS Pathogens, 2015
- TLR5 puts the brakes onNature Reviews Microbiology, 2013
- Safety Notice for the Use of Drugs for Intravesical Instillations and Cost AnalysisUrologia Journal, 2013
- Intravesical treatments of bladder pain syndrome/interstitial cystitisNature Reviews Urology, 2012
- A hydrogel derived from decellularized dermal extracellular matrixBiomaterials, 2012
- Antibacterial Activity of Glutathione-Coated Silver Nanoparticles against Gram Positive and Gram Negative BacteriaLangmuir, 2012
- A murine model of urinary tract infectionNature Protocols, 2009
- (Poly)acrylonitrile-based hydrogel as a therapeutic bulking agent in urologyBiomaterials, 2007